SCHEMBL4757428

SCHEMBL4757428

Cc1cc(O)c(C(=O)Nc2nc(NS(C)(=O)=O)c(C)s2)cc1Cl

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.42
RAB9A P51151 5/20 0.42
RXFP1 Q9HBX9 4/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
HSD17B10 Q99714 1/20 0.39
POLA1 P09884 1/20 0.38
TASP1 Q9H6P5 1/20 0.37
GPR27 Q9NS67 3/20 0.36
PIK3CA P42336 1/20 0.36
PIK3CB P42338 1/20 0.36
KDM4E B2RXH2 4/20 0.35
NPSR1 Q6W5P4 2/20 0.35
LMNA P02545 1/20 0.35
POLB P06746 1/20 0.35
MAPT P10636 1/20 0.35
NPY1R P25929 1/20 0.35
HTT P42858 1/20 0.35
NPY2R P49146 1/20 0.35
PLTP P55058 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4757405 0.81 MEN1 (0.46) NPC1RAB9ARXFP1MEN1KMT2A
SCHEMBL4757423 0.79 RAB9A (0.39) NPC1RAB9ARXFP1MEN1KMT2A
SCHEMBL4757495 0.74 KDM4E (0.36) NPC1RAB9ARXFP1MEN1KMT2A
SCHEMBL10131687 0.68 NPC1 (0.44) NPC1RAB9AMEN1KMT2AHSD17B10
SCHEMBL4756598 0.67 GRM4 (0.52) NPC1RAB9AMEN1KMT2APOLB
SCHEMBL4757410 0.67 NPC1 (0.42) NPC1RAB9ARXFP1MEN1KMT2A
SCHEMBL15916250 0.66 RAB9A (0.67) NPC1RAB9ARXFP1MEN1KMT2A
SCHEMBL4757341 0.66 GPR27 (0.43) NPC1RAB9ARXFP1MEN1KMT2A
SCHEMBL4757200 0.66 FFAR2 (0.47) NPC1RAB9ARXFP1MEN1KMT2A
SCHEMBL6812308 0.66 ALDH1A1 (0.48) MEN1KMT2AHSD17B10KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES, L.C. 2012-05-17 US disclosed
US-8124632-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES, L.C. (US) 2012-02-28 US disclosed
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES L.C. 2009-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC NPC1 585/4885RAB9A 1694/4885RXFP1 4741/4885
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC NPC1 585/4885RAB9A 1694/4885RXFP1 4741/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.